Jodi A. Muscal

A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: A Children's Oncology Group phase I consortium study (ADVL0916)

Jodi A. Muscal, Patrick A. Thompson, Terzah M. Horton et al. · Pediatric Blood & Cancer · 2012 · 84 citations

Pharmacy, Oncology, Pharmacology +14

A Phase I Trial of Imetelstat in Children with Refractory or Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Study (ADVL1112)

Patrick A. Thompson, Rachid Drissi, Jodi A. Muscal et al. · Clinical Cancer Research · 2013 · 81 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Plasma and cerebrospinal fluid pharmacokinetics of thalidomide and lenalidomide in nonhuman primates

Jodi A. Muscal, Yongkai Sun, Jed G. Nuchtern et al. · Cancer Chemotherapy and Pharmacology · 2011 · 53 citations

Medicine, Pharmacokinetics, Pharmacology +10

Novel ALK inhibitor AZD3463 inhibits neuroblastoma growth by overcoming crizotinib resistance and inducing apoptosis

Yongfeng Wang, Long Wang, Shan Guan et al. · Scientific Reports · 2016 · 52 citations · Full text

Medicine, Oncology, Pharmacology +17

Mucoepidermoid Carcinoma in Children: A Single Institutional Experience

Piti Techavichit, John Hicks, Dolores López‐Terrada et al. · Pediatric Blood & Cancer · 2015 · 45 citations

Medicine, Oncology, Surgery +17